ELEVATED THYROID STIMULATING HORMONE AS A POTENTIAL BIOMARKER FOR RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY Conference Paper uri icon

authors

  • Liew, D
  • Leung, J
  • McMaster, C
  • Djukiadmodjo, F
  • Liu, B
  • Cebon, J
  • Frauman, A
  • Buchanan, R

publication date

  • May 1, 2018